Search research articles
Contact Us
Filters
Showing results (1-10 of 199) with videos related to
Page
of 20
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 2, 2019
Unraveling the Role of Nonsteroidal Antiinflammatory Drugs in the Link Between Osteoarthritis and Cardiovascular Disease via Causal Mediation Analysis: A Guide to Interpretation
Kazuki Yoshida, Rishi J Desai
Current Opinion in Rheumatology
|
December 17, 2016
Use of large healthcare databases for rheumatology clinical research
Rishi J Desai, Daniel H Solomon
BMJ (Clinical Research Ed.)
|
October 25, 2019
Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
Rishi J Desai, Jessica M Franklin
American Journal of Epidemiology
|
July 16, 2024
A future of data-rich pharmacoepidemiology studies: transitioning to large-scale linked electronic health record + claims data
Sebastian Schneeweiss, Rishi J Desai, Robert Ball
Pharmacoepidemiology and Drug Safety
|
July 27, 2025
Comparative Safety of Biologic and Targeted-Synthetic DMARDs in Patients With Rheumatoid Arthritis: A Multi-Database Real-World Cohort Study
Yinzhu Jin, Jun Liu, Rishi J Desai
Journal of Cardiac Failure
|
February 3, 2022
Rates of Spironolactone Initiation and Subsequent Hyperkalemia Hospitalizations in Patients with Heart Failure with Preserved Ejection Fraction Following the TOPCAT trial: A Cohort Study of Medicare Beneficiaries
Rishi J Desai, Scott D Solomon, Muthiah Vaduganathan
Clinical Pharmacology and Therapeutics
|
June 30, 2026
Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors
Katherine L Crum, Muthiah Vaduganathan, Rishi J Desai
Journal of the American Heart Association
|
July 14, 2023
Initiation Patterns of Disease-Modifying Antirheumatic Drugs That Have Potential to Exacerbate Heart Failure
Su Been Lee, Elvira D'Andrea, Rishi J Desai
Clinical Pharmacology and Therapeutics
|
December 30, 2018
Role of Authorized Generics in Postapproval Surveillance of Generic Drug Products
Joshua J Gagne, Ameet Sarpatwari, Rishi J Desai
Kidney International
|
January 5, 2023
Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
Edouard L Fu, Alexander Kutz, Rishi J Desai
Page
of 20
Search research articles
Search
Showing results (1-10 of 199) with videos related to
Sort By:
Page
of 20
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 2, 2019
Unraveling the Role of Nonsteroidal Antiinflammatory Drugs in the Link Between Osteoarthritis and Cardiovascular Disease via Causal Mediation Analysis: A Guide to Interpretation
Kazuki Yoshida, Rishi J Desai
Current Opinion in Rheumatology
|
December 17, 2016
Use of large healthcare databases for rheumatology clinical research
Rishi J Desai, Daniel H Solomon
BMJ (Clinical Research Ed.)
|
October 25, 2019
Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
Rishi J Desai, Jessica M Franklin
American Journal of Epidemiology
|
July 16, 2024
A future of data-rich pharmacoepidemiology studies: transitioning to large-scale linked electronic health record + claims data
Sebastian Schneeweiss, Rishi J Desai, Robert Ball
Pharmacoepidemiology and Drug Safety
|
July 27, 2025
Comparative Safety of Biologic and Targeted-Synthetic DMARDs in Patients With Rheumatoid Arthritis: A Multi-Database Real-World Cohort Study
Yinzhu Jin, Jun Liu, Rishi J Desai
Journal of Cardiac Failure
|
February 3, 2022
Rates of Spironolactone Initiation and Subsequent Hyperkalemia Hospitalizations in Patients with Heart Failure with Preserved Ejection Fraction Following the TOPCAT trial: A Cohort Study of Medicare Beneficiaries
Rishi J Desai, Scott D Solomon, Muthiah Vaduganathan
Clinical Pharmacology and Therapeutics
|
June 30, 2026
Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors
Katherine L Crum, Muthiah Vaduganathan, Rishi J Desai
Journal of the American Heart Association
|
July 14, 2023
Initiation Patterns of Disease-Modifying Antirheumatic Drugs That Have Potential to Exacerbate Heart Failure
Su Been Lee, Elvira D'Andrea, Rishi J Desai
Clinical Pharmacology and Therapeutics
|
December 30, 2018
Role of Authorized Generics in Postapproval Surveillance of Generic Drug Products
Joshua J Gagne, Ameet Sarpatwari, Rishi J Desai
Kidney International
|
January 5, 2023
Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
Edouard L Fu, Alexander Kutz, Rishi J Desai
Page
of 20